Literature DB >> 7889373

Effect of corticosterone on the enhancement of the acoustic startle reflex by corticotropin releasing factor (CRF).

Y Lee1, J Schulkin, M Davis.   

Abstract

The present study evaluated the effects of adrenalectomy and chronic administration of corticosterone on the ability of CRF given intraventricularly to increase the amplitude of the acoustic startle reflex in rats. Experiment 1 showed that CRF-enhanced startle was not affected by adrenalectomy, indicating a central effect independent of the integrity of the hypothalamic-pituitary-adrenal axis. In Experiment 2, chronic injection of corticosterone augmented CRF-enhanced startle using a dose of CRF (0.25 micrograms) that normally is ineffective in increasing startle amplitude. Chronic injection of corticosterone by itself did not increase startle amplitude (Experiment 3). We suggest that the potentiation of CRF-enhanced startle by corticosterone may result from an activation of CRF in the central nucleus of the amygdala.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7889373     DOI: 10.1016/0006-8993(94)90286-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  19 in total

Review 1.  Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus?

Authors:  Mitchel A Kling; Victoria H Coleman; Jay Schulkin
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

Review 2.  Role of corticotropin releasing factor in anxiety disorders: a translational research perspective.

Authors:  Victoria B Risbrough; Murray B Stein
Journal:  Horm Behav       Date:  2006-07-25       Impact factor: 3.587

3.  Adrenal activity during repeated long-access cocaine self-administration is required for later CRF-Induced and CRF-dependent stressor-induced reinstatement in rats.

Authors:  Evan N Graf; Michael A Hoks; Jean Baumgardner; Jose Sierra; Oliver Vranjkovic; Colin Bohr; David A Baker; John R Mantsch
Journal:  Neuropsychopharmacology       Date:  2011-03-16       Impact factor: 7.853

4.  Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone.

Authors:  M L Wong; M A Kling; P J Munson; S Listwak; J Licinio; P Prolo; B Karp; I E McCutcheon; T D Geracioti; M D DeBellis; K C Rice; D S Goldstein; J D Veldhuis; G P Chrousos; E H Oldfield; S M McCann; P W Gold
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

5.  Hydrocortisone suppression of the fear-potentiated startle response and posttraumatic stress disorder.

Authors:  Mark W Miller; Ann E McKinney; Fredrick S Kanter; Kristina J Korte; William R Lovallo
Journal:  Psychoneuroendocrinology       Date:  2011-01-26       Impact factor: 4.905

6.  Corticosterone controls the developmental emergence of fear and amygdala function to predator odors in infant rat pups.

Authors:  Stephanie Moriceau; Tania L Roth; Terri Okotoghaide; Regina M Sullivan
Journal:  Int J Dev Neurosci       Date:  2004 Aug-Oct       Impact factor: 2.457

7.  A review of adversity, the amygdala and the hippocampus: a consideration of developmental timing.

Authors:  Nim Tottenham; Margaret A Sheridan
Journal:  Front Hum Neurosci       Date:  2010-01-08       Impact factor: 3.169

8.  Postnatal ablation of POMC neurons induces an obese phenotype characterized by decreased food intake and enhanced anxiety-like behavior.

Authors:  Yona Greenman; Yael Kuperman; Yonat Drori; Sylvia L Asa; Inbal Navon; Oren Forkosh; Shosh Gil; Naftali Stern; Alon Chen
Journal:  Mol Endocrinol       Date:  2013-05-15

Review 9.  Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety.

Authors:  Michael Davis; David L Walker; Leigh Miles; Christian Grillon
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

10.  CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats.

Authors:  Sheila E Specio; Sunmee Wee; Laura E O'Dell; Benjamin Boutrel; Eric P Zorrilla; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2007-10-30       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.